POSACONAZOLE AHCL 40 mg/ml, oral suspension bottle, 105 ml
Active ingredients: Posaconazole
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 105 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- POSACONAZOLE AHCL 40 mg/mL, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) avec fermeture de sécurité enfant de 105 ml avec cuillère-mesure
- Marketing authorisation holder
- ACCORD HEALTHCARE (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 May 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63474691CIP73018684CIP133400930186848Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POSACONAZOLEsuspension | 40 mg · 1 mL de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.